Abstract:An efficient and sensitive ultra-performance liquid chromatography-tandem mass spectrometry method has been developed and validated to simultaneously determine and quantify vasicine (VAS) and its major metabolites including vasicinone (VAO), 9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b] quinazolin-3-yl hydrogen sulfate (VAOS), 1,2,3,9-tetrahydro-pyrrolo[2,1-b] quinazolin-3-yl hydrogen sulfate (VASS), 1,2,3,9-tetrahydropyrrolo[ 2,1-b] quinazolin-3-b-D-glucuronide (VASG), vasicinol (VASL) and vasicinolone (VAOL) using pseudoephedrine as the internal standard in rat plasma. The chromatographic separation was conducted on a HSS T3 column (100 mm x 2.1 mm, 1.8 mu m) with the gradient elution using a mobile phase of methanol-0.1% formic acid in water at a flow rate of 0.4 mL min(-1) for 7 min. The tandem mass spectrometric detection was conducted using multiple reaction monitoring (MRM) by positive electrospray ionization (ESI). The corresponding lower limits of quantitation (LLOQ) of the method were 0.73, 0.80, 0.75, 0.80, 0.82, 0.87, 0.82 ng mL(-1) for VAO, VAOS, VASS, VASG, VAS, VASL and VAOL, respectively. The within-and between-run precision for all analytes were less than 7.66% and 12.30%, respectively. The recovery for all analytes was between 85.89% and 114.58%, and the matrix effects for all analytes were not observed. By the UPLC-MS/MS method, the relative quantitation of five metabolites of 9-oxo-1,2,3,9-tetrahydropyrrolo[2,1-b] quinazolin-3-beta-D-glucuronide (VAOG), hydroxylation-acetylation products of VAS (HVAS1 and HVAS2) and methylation-acetylation products of VAS (MVAS1 and MVAS2) were achieved by standard curves derived from the urine sample with treatment by VAS as a reference substance, in which the considerable target metabolites were included. This method was successfully applied to pharmacokinetic studies of VAS and its metabolites in rats. The activity of the components in plasma after intravenous administration of VAS (2 mg kg(-1)) was evaluated by in vitro antibutyrylcholinesterase assays. The results indicated that in vivo butyrylcholinesterase inhibitive activities were mainly due to the different concentrations of prototype VAS and a few other metabolites.

Determination of GL-V9, a Derivative of Wogonin, in Rat Plasma by UPLC-MS/MS and Its Application to a Pharmacokinetic Study after Oral and Pulmonary Administration.

Simultaneous Determination Of Notoginsenoside R1, Ginsenoside Rg(1), Re, Rb-1 And Icariin In Rat Plasma By Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry

Mechanistic Study of Absorption and First-Pass Metabolism of GL-V9, a Derivative of Wogonin

Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of wogonin in rats.

Pharmacokinetics, tissue distribution, and excretion study of GL‐V9 and its glucuronide metabolite 5‐O‐glucuronide GL‐V9 in Sprague–Dawley rats

An Investigation on Glucuronidation Metabolite Identification, Isozyme Contribution, and Species Differences of GL-V9 In Vitro and In Vivo.

Trace quantification of GL-V9 and its glucuronide metabolites (5-O-glucuronide GL-V9) in Beagle dog plasma by UPLC–MS/MS and its application to a pharmacokinetic study

Simultaneous LC–MS Analysis and of Wogonin and Oroxylin A in Rat Plasma, and Pharmacokinetic Studies after Administration of the Active Fraction from Xiao-Xu-Ming Decoction

Development and Validation of a Highly Rapid and Sensitive LC–MS/MS Method for Determination of SZ-685C, an Investigational Marine Anticancer Agent, in Rat Plasma – Application to a Pharmacokinetic Study in Rats

Development and Validation of an Uflc-Ms/Ms Assay for the Absolute Quantitation of Nine Notoginsenosides in Rat Plasma: Application to the Pharmacokinetic Study of Panax Notoginseng Extract

A Rapid and Sensitive UPLC–MS/MS Method for Determination of HZ08 in Rat Plasma and Tissues: Application to a Pharmacokinetic Study of Liposome Injections

Metabolite Identification and the Development of a Simultaneous Quantification Method for Wogonin and Wogonin-7-o-glucuronide: Application to a Distribution Study in Mice Liver

LC Determination and Pharmacokinetic Study of Vitexin-4″-o-glucoside in Rat Plasma after Oral Administration

Determination of astragaloside III in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study

An LC-MS Method for Simultaneous Determination of Nine Ginsenosides in Rat Plasma and Its Application in Pharmacokinetic Study.

High-Performance Liquid Chromatographic Method for the Determination and Pharmacokinetic Study of Wogonoside in Rat Serum after Oral Administration of Traditional Chinese Medicinal Preparation Huang-Lian-Jie-Du Decoction

A Simple and Rapid Method for the Determination of Pennogenin Diglycoside in Rat Plasma by Hplc-Ms: Application to the Pharmacokinetics of the Extract in Gongxuening Capsules

A validated HPLC-MS/MS method for determination of genipin-1-o-glucuronic acid in rat plasma after dministration of genipin and its application to a pharmacokinetic study

Determination of Deltonin in Rat Plasma by Using Hplc-Ms/Ms and the Application of This Method in Pharmacokinetic Studies

Simultaneous determination of vasicine and its major metabolites in rat plasma by UPLC-MS/MS and its application to in vivo pharmacokinetic studies

The Development and Validation of an LC-MS/MS Method for the Quantification of CZ112, a Prodrug of 9-Nitrocamptothecin in Rat Plasma